Logos Global Management LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$44,217,000
-5.6%
850,000
-51.4%
3.79%
-36.7%
Q3 2020$46,830,000
+182.8%
1,750,000
+105.9%
5.99%
+81.1%
Q2 2020$16,558,000
+573.6%
850,000
+240.2%
3.31%
+253.9%
Q1 2020$2,458,000249,8440.94%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders